Forward P/S Multiple: Asensus Surgical Inc (ASXC)

Asensus Surgical - graphic logo of issuer ASXC

Asensus Surgical, Inc. (ASXC) generates revenue through the sale of disposable instruments and AI licenses for its robots. This forward P/S chart visualizes these expectations, where the value 9.70 determines the parameter status. The business faces challenges competing against an industry monopolist without unique advantages; however, a stable workforce of loyal engineers and software developers ensures reliable technological support for the company.

Asensus Surgical - ASXC Market Cap to Projected Revenue (period 07/04/2022 - 08/31/2024)

Summary analytical data breakdowns for asensus.com (ASXC)

- market price and analyst price targets:
Price Chart Asensus Surgical|ASXC - Consensus Target
- company stock exchange capitalization indicators:
Market Capitalization ASXC|ASXC - Total Enterprise Value
- issuer book value statistics:
Book Value per Share Asensus Surgical|ASXC - Accounting Capitalization|Market Capitalization to Book Value Ratio asensus.com|ASXC - Company Total Asset Base
- debt and liquidity data:
Total Debt to Capital Asensus Surgical, Inc.|ASXC - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Asensus Surgical|ASXC - Company Aggregate Debts|Debt to Book Capitalization Ratio ASXC|ASXC - Company Long-Term Debt|Company Current Liabilities Asensus Surgical|Quick Ratio asensus.com
- financial results and valuation multiples details:
ASXC - Company Net Income|Expected Profit Asensus Surgical, Inc.|ASXC - Market Cap to Net Income Ratio|Projected Price to Earnings Asensus Surgical|ASXC - PEG Multiple|EV/EBITDA Multiple ASXC|ASXC - Operating income before deduction of amortization|Earnings per share for the last twelve months Asensus Surgical|ASXC - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months asensus.com|ASXC - Net earnings per share growth this year|Earnings growth forecast for next year Asensus Surgical, Inc.
- sales and revenue indicators:
ASXC - Company Total Revenue|Company Projected Revenue Asensus Surgical|ASXC - Market Cap to Revenue Ratio|Forward Price-to-Revenue Multiple ASXC
Fundamental company analysis:ASXC (TransEnterix)
Product sample of asensus.com

The forward P/S is calculated as the ratio of current market capitalization to projected revenue, measuring market expectations regarding business growth rates. The stability of this ratio determines the maturity of the model, where the efficiency of surgical robot logistics and consumables supply directly impacts revenue, which this forward price-to-sales chart clearly reflects when analyzing the investment attractiveness of Asensus Surgical, Inc. (ASXC).

Who Asensus Surgical, Inc. competes with

Price-to-Projected Revenue Ratio Dexcom DXCM|PEN - Forward Price-to-Revenue Multiple|Novanta Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Haemonetics Company|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED) - Forward P/S Multiple|Pulse Biosciences Inc (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward Price-to-Revenue Multiple Picard Group PMI|Forward P/S Multiple SRDX (Surmodics, Inc.)|Forward P/S Multiple senseonics.com SENS|NPCE - Price-to-Projected Revenue Ratio|TCMD: Price-to-Projected Revenue Ratio|SNWV (SANUWAVE Health, Inc.) - Forward Price-to-Revenue Multiple|Outset Medical Corp - Forward Price to Sales|ELMD (SmartVest) - Forward P/S Multiple|Market Cap to Future Revenue Ratio lensar.com LNSR|Price-to-Projected Revenue Ratio AVITA Medical (RCEL)|profoundmedical.com (PROF) - Projected Price to Revenue|Baird Medical - Forward Price-to-Revenue Multiple|Forward P/S Multiple EDAP TMS SA EDAP|Bovie Medical - Forward P/S Multiple|Market Cap to Expected Sales Ratio IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Price-to-Projected Revenue Ratio|Future Price to Revenue TELA (TELA Bio)|Price-to-Projected Revenue Ratio CytoSorbents Corp|Forward Price-to-Revenue Multiple Sensus (SRTS)|Forward P/S Multiple ZYXI|ECOR - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Vicarious Surgical RBOT|IINN: Market Cap to Projected Revenue|ICU: Forward Price-to-Revenue Multiple|IRIDEX Corporation - Price to Expected Revenue Ratio|INBS: Forward P/S Multiple|Beyond Air (XAIR) - Forward P/S Multiple|Price-to-Projected Revenue Ratio Profusa|STRATA Skin (SSKN) - Market Cap to Expected Sales Ratio|Forward P/S Multiple GCTK|NAOV - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Venus Concept Inc. VERO|NUWE: Market Cap to Projected Revenue|AEMD - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio Avinger Inc. AVGR|BSGM (BioSig Technologies, Inc) - Forward Price-to-Revenue Multiple|Cutera Inc (CUTR) - Forward P/S Multiple|Price-to-Projected Revenue Ratio Know Labs, Inc.|inarimedical.com (NARI) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple NVRO (Nevro)|RSLS (reshapelifesciences.com) - Forward Price to Sales|Price-to-Projected Revenue Ratio Silk Road Medical Inc. SILK